UPDATE: TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy

Accuray Incorporated ARAY announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated TOMO by Accuray. More than 98 percent of votes cast and 79 percent of shares outstanding were voted in favor of the transaction. The companies anticipate the closing of the transaction will occur within one to two business days, assuming all other customary closing conditions are met. The combination of Accuray and TomoTherapy will bring together best-in-class technologies to create the premier radiation oncology company. The combined company will focus on developing, manufacturing and selling innovative, personalized treatment solutions that revolve around the patient.